2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow ICON Bioscience Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery Dexamethasone, Prednisolone - Cataract | Phase 3 | Completed | ICON Bioscience Inc | 194 | 2015-11-06 | 2018-08-21 |
| The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery IBI-10090, Placebo - Inflammation, Cataracts | Phase 3 | Completed | ICON Bioscience Inc | 394 | 2014-01-01 | 2018-04-23 |
Cataract (2) · Inflammation (1)
Calcium Dobesilate (2) · Dexamethasone (1) · Prednisolone (1) · Standard of Care (1)
United States (2)